Tradestie Institutional Equity Comparison Engine

XNCR vs MGNX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MGNX Overall Edge

MGNX Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MacroGenics, Inc. (MGNX) driven by superior Valuation, Growth & Margin while XNCR counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, XNCR trades at 68.0x Forward P/E with -72.7% operating margin (+454.9% YoY revenue) versus MGNX at 61.0x Forward P/E and -21.7% operating margin (+378.0% YoY). In options structure, XNCR sits in BREAKOUT (10th %ile IV; Dealer Gamma Walls on Pro) against MGNX sits in BREAKDOWN (1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner MGNX
XNCR 68.0x vs MGNX 61.0x Fwd P/E
Growth & Margin Winner MGNX
Op Margin -72.7% vs -21.7% ยท YoY +454.9% vs +378.0%
Momentum & Technical Winner XNCR
1Y +154.5% vs +32.8% ยท 52W Pos 84% vs 21%
Options & Structure Winner XNCR
BREAKOUT (10th %ile IV) vs BREAKDOWN (1st %ile IV)
XNCR NASDAQ
Xencor, Inc.
Pharmaceutical Preparations
$35.61
-3.99% 1D
Market Cap $2.9B
1M Return +55.84%
1Y Return +154.54%
Forward P/E 68.0x
Unified AI Score
29.6 / 100 SELL
Tech 50.0 Fund 32.0 Flow 66.0 Mom 40.0
MGNX NASDAQ
MacroGenics, Inc.
Pharmaceutical Preparations
$2.12
-3.41% 1D
Market Cap $145.9M
1M Return -34.62%
1Y Return +32.81%
Forward P/E 61.0x
Unified AI Score
43.6 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 65.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: XNCR +154.54% MGNX +32.81% Spread: +121.73 pp (XNCR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period XNCR Revenue MGNX Revenue XNCR Op. Margin MGNX Op. Margin Margin Edge
FY2018 $40M $60M -195.5% -284.8% XNCR
FY2019 $160M $60M 8.8% -276.0% XNCR
FY2020 $120M $100M -62.6% -125.0% XNCR
FY2021 $280M $80M 15.9% -261.9% XNCR
FY2022 $160M $150M -50.1% -79.9% XNCR
FY2023 $170M $60M -75.8% -286.4% XNCR
FY2024 $110M $150M -161.5% -73.7% MGNX
FY2025 $130M $150M -141.4% -48.7% MGNX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: XNCR (5) vs MGNX (5)
Institutional Metric XNCR MGNX Criterion Row Winner
Market Capitalization Scale $2.9B $145.9M Larger Scale XNCR
Trailing P/E Ratio Valuation 68.0x 61.0x Lower Multiple MGNX
Forward P/E Ratio Valuation 68.0x 61.0x Lower Multiple MGNX
Revenue Growth (YoY) Growth +454.9% +378.0% Higher Growth XNCR
Operating Margin (TTM) Profitability -72.7% -21.7% Higher Margin MGNX
Net Profit Margin Profitability -58.8% -8.3% Higher Margin MGNX
Return on Equity (ROE) Capital Efficiency -19.9% -225.9% Higher ROE XNCR
52-Week Range Position Momentum 84% ($10โ€“$41) 21% ($1โ€“$5) Stronger Trend XNCR
Beta / 30D Volatility Risk Regime 1.21ฮฒ ยท 87% Vol 1.36ฮฒ ยท 147% Vol Lower Realized Risk XNCR
Unified Institutional Score Composite Signal 29.6 / 100 (SELL) 43.6 / 100 (HOLD) Higher Composite MGNX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full XNCR vs MGNX Buy Guide
XNCR BREAKOUT
58d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live XNCR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MGNX BREAKDOWN
122d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 1st %ile
IV Regime Compressed (<25th %ile)
Live MGNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither XNCR nor MGNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.